[1] Krieg,M,Meurer M.Systemic scleroderma:clinical and pathophysiologic aspects.J Am Acad Dermatol,1988,18:457.
[2] UmeharaH,kumagais,IshidaH,et al.Enhanced production of interleukin-2 In Patients with Progressive systemic sclerosis:hypereactivity of CD4-positive T cells?
[3] Arthritis Rheum,1988,31:401.
[4] Kahaleh MB,LeRoy EC.Interleukin-2 in scleroderma:correlation of serum level with extent of skin involvement and disease duration.Ann Intern Med,1989,110:446.
[5] DegiannisD,Seibold JR,CzarneckiM,Raskova J.et al.Soluble interleukin-2 recePtors in Patients with systemic sclerosis:clinical and laboratory correlations.Arthritis Rheum,1990,33:375. |